BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2025 2:50:54 AM | Browse: 22 | Download: 63
 |
Received |
|
2025-09-27 16:51 |
|
Peer-Review Started |
|
2025-09-27 16:51 |
|
First Decision by Editorial Office Director |
|
2025-10-21 09:35 |
|
Return for Revision |
|
2025-10-21 09:35 |
|
Revised |
|
2025-10-28 11:21 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-12 02:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-12 11:12 |
|
Articles in Press |
|
2025-11-12 11:12 |
|
Edit the Manuscript by Language Editor |
|
2025-11-14 10:06 |
|
Typeset the Manuscript |
|
2025-12-14 04:54 |
|
Publish the Manuscript Online |
|
2025-12-27 02:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Editorial |
| Article Title |
Harnessing early enzymatic biomarkers and cytokines for risk prediction in post-endoscopic retrograde cholangiopancreatography pancreatitis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abdellatif Bouayad |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abdellatif Bouayad, Associate Professor, MD, Laboratory of Immunology, Mohammed First University, Faculty of Medicine and Pharmacy Oujda, 4867 Oujda l’Université, Oujda-Angad 4867, Oriental, Morocco. a.bouayad@ump.ac.ma |
| Key Words |
Cytokines; Enzymatic biomarkers; Post-endoscopic retrograde cholangiopancreatography pancreatitis; Early diagnosis; Prognosis |
| Core Tip |
Although high serum 4-hour amylase and lipase levels enable early diagnosis of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis, they have limited prognostic value and lack etiological specificity. Interleukin (IL)-6 has emerged as an early inflammatory biomarker for predicting post-ERCP pancreatitis severity. Nevertheless, detection and quantification of this cytokine remain costly. Validation of rapid, cost-effective, and point-of-care IL-6 immunoassays is essential for their integration into routine clinical practice for post-ERCP pancreatitis risk prediction. |
| Publish Date |
2025-12-27 02:50 |
| Citation |
Bouayad A. Harnessing early enzymatic biomarkers and cytokines for risk prediction in post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastroenterol 2025; 31(48): 114786 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i48/114786.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i48.114786 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
